Milton C. Ault III - 26 Sep 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
26 Sep 2025
Net transactions value
-$184,156
Form type
4
Filing time
30 Sep 2025, 19:15:07 UTC
Previous filing
26 Sep 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 30 Sep 2025 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale $87,345 -37,738 -34% $2.31 73,516 26 Sep 2025 By Ault Lending, LLC F1
transaction ALZN Common Stock Sale $88,490 -38,324 -52% $2.31 35,192 29 Sep 2025 By Ault Lending, LLC F1
transaction ALZN Common Stock Sale $8,321 -3,566 -10% $2.33 31,626 30 Sep 2025 By Ault Lending, LLC F1
holding ALZN Common Stock 1,843 26 Sep 2025 Direct
holding ALZN Common Stock 11,068 26 Sep 2025 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 61 26 Sep 2025 By Ault Life Sciences Fund, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.